Andrew Cheng - President and CEO, Director at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
AKRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Andrew Cheng - trading volume in the past year for Akero Therapeutics, Inc.

Holdings reported by Andrew Cheng for Akero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 605K $19.7M $32.50 Nov 1, 2024 Direct
Stock Option (Right to Buy) 136K Nov 1, 2024 Direct Common Stock
Stock Option (Righto Buy) 93.7K Oct 18, 2024 Direct Common Stock

Transactions reported by Andrew Cheng for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.